Cleared Traditional

Latitud Hip Replacement System (K183532) - FDA 510(k) Clearance

Class II Orthopedic device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K183532 · Meril Healthcare Pvt. , Ltd. · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2019
Decision
211d
Days
Class 2
Risk

K183532 is an FDA 510(k) clearance for the Latitud Hip Replacement System. Classified as Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented (product code LZO), Class II - Special Controls.

Submitted by Meril Healthcare Pvt. , Ltd. (Vapi, IN). The FDA issued a Cleared decision on July 18, 2019 after a review of 211 days - an extended review cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3353 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Meril Healthcare Pvt. , Ltd. devices

Submission Details

510(k) Number K183532 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 19, 2018
Decision Date July 18, 2019
Days to Decision 211 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
89d slower than avg
Panel avg: 122d · This submission: 211d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LZO Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3353
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - LZO Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented

All 291
Devices cleared under the same product code (LZO) and FDA review panel - the closest regulatory comparables to K183532.
Wagner SL Revision Stem Lateral and Wagner Cone Prosthesis System
K191781 · Zimmer GmbH · Aug 2019
Corin Optimized Position System Functional Hip Analysis (OPS FHA)
K190834 · Corin USA · Jul 2019
Revival Modular Hip Stem
K191374 · Corin U.S.A. Limited · Jul 2019
MasterLoc Extension
K191145 · Medacta International S.A. · May 2019
MobileLink Acetabular Cup System
K182321 · Waldemar Link GmbH & Co. KG · May 2019
Delta Dual Mobility System
K181491 · Lima Corporate S.P.A. · May 2019